(IBTM) iShares iBonds Dec 2032 - Ratings and Ratios
Treasury Bond, ETF, Index, Maturity
| Risk via 10d forecast | |
|---|---|
| Volatility | 4.01% |
| Value at Risk 5%th | 6.59% |
| Relative Tail Risk | 0.02% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.61 |
| Alpha | 3.06 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.500 |
| Beta | -0.034 |
| Beta Downside | -0.069 |
| Drawdowns 3y | |
|---|---|
| Max DD | 10.28% |
| Mean DD | 2.87% |
| Median DD | 2.62% |
Description: IBTM iShares iBonds Dec 2032 October 27, 2025
The iShares iBonds Dec 2032 Term Treasury ETF (IBTM) tracks a market-value-weighted index of U.S. Treasury securities, with each security’s weight reduced by any amount held by the Federal Reserve’s System Open Market Account (SOMA). The fund is required to hold at least 80 % of its assets in the index’s component securities and at least 90 % in U.S. Treasuries that BlackRock’s Fixed-Income Allocation team deems appropriate for tracking the index, except during the final months before the fund’s scheduled termination in 2032.
Key quantitative drivers to watch include the fund’s effective duration-currently around 10 years-which makes its price highly sensitive to changes in the Federal Reserve’s policy rate. As of the latest data, the weighted-average yield to maturity sits near 4.5 %, reflecting the steepening of the Treasury curve after the 2023-2024 rate-hiking cycle. Inflation expectations and the Treasury market’s supply dynamics (e.g., the size of new 10-year and 30-year issuances) are primary macro-economic levers that will influence IBTM’s total return and its glide-path cash-flow schedule.
For a deeper dive into IBTM’s projected cash flows and risk profile, the ValueRay platform offers interactive tools that can help you model different rate scenarios.
IBTM ETF Overview
| Market Cap in USD | 468m |
| Category | Target Maturity |
| TER | 0.07% |
| IPO / Inception | 2022-07-06 |
| Return 12m vs S&P 500 | -5.50% |
| Analyst Rating | - |
IBTM Dividends
| Dividend Yield | 3.85% |
| Yield on Cost 5y | 4.09% |
| Yield CAGR 5y | 66.26% |
| Payout Consistency | 100.0% |
| Payout Ratio | - |
IBTM Growth Ratios
| CAGR 3y | 3.63% |
| CAGR/Max DD Calmar Ratio | 0.35 |
| CAGR/Mean DD Pain Ratio | 1.27 |
| Current Volume | 89.9k |
| Average Volume | 89.9k |
What is the price of IBTM shares?
Over the past week, the price has changed by -0.04%, over one month by -0.06%, over three months by +1.55% and over the past year by +7.64%.
Is iShares iBonds Dec 2032 a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBTM is around 22.29 USD . This means that IBTM is currently overvalued and has a potential downside of -3.71%.
Is IBTM a buy, sell or hold?
What are the forecasts/targets for the IBTM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 25.2 | 9% |
IBTM Fundamental Data Overview November 04, 2025
Beta = 1.15
Revenue TTM = 0.0 USD
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 468.4m USD (468.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 468.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 468.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 10.25% (E(468.4m)/V(468.4m) * Re(10.25%) + (debt-free company))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Fair Price DCF = unknown (Cash Flow 0.0)
Additional Sources for IBTM ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle